Why Boston Scientific Corporation (BSX) Is Among the Best Medical Device Stocks to Buy Now

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best medical device stocks to buy now.

Trump’s Tariffs Are Dividing the Medical Community

On April 16, CNBC reported that Trump’s tariffs are building a divide in the medical community. The first Trump administration did not impose tariffs on medical devices and protective gear manufactured in Mexico, China, and Canada. However, the sector has not received a reprieve from the president’s newest round of duties so far. This has resulted in a division: since device makers could potentially face significant challenges from tariffs, they are pushing back for a way out. In contrast, personal protective equipment manufacturers stand to benefit from the barriers created by the levies, which is why they are not showing signs of a push back.

The medical community is thus presenting a dichotomy in the face of tariffs. CNBC reported that the duties could also raise costs for hospitals, and in turn, patients, ultimately reducing access to critical care and equipment. Scott Whitaker, CEO of AdvaMed, the trade group representing medical technology and device makers, said the following about the situation:

“MedTech supply chain leaders are already reporting supply chain concerns, and we cannot afford to drive up the cost of health care for patients, or on the health care system. The reality is, any increased costs will be largely borne by taxpayer-funded health programs like Medicare, Medicaid, and the VA.”

Hospital trade groups are also voicing their concerns, warning that tariffs could bring the quality of care down. CNBC reported that Rick Pollack, the CEO of the American Hospital Association, opined:

“The AHA has and will continue to share with the Administration, disruptions in the availability of these critical devices — many of which are sourced internationally — have the potential to disrupt patient care. AHA continues to push for a tariff exemption for medical devices to ensure that hospitals and health systems can continue to serve their patients and communities.”

READ ALSO: Recession Resistant Investing: 10 Best Grocery Stocks To Buy Now and 11 Most Promising Future Stocks According to Hedge Funds.

Pricing Complexity in the Medical Device Sector

President Trump imposed a 25% tariff on imported goods from Mexico and Canada in February, later delaying levies on a number of items falling under the US-Mexico-Canada Agreement. However, Chinese goods have not seen any reprieve. In fact, the new levies imposed in Trump’s second term have brought the total tariff rate up to 145%. While a way out of the present conditions is to raise prices to offset the rising expenses from tariffs, a range of hospitals and other organizations buying medical equipment cannot do so. These institutions are thus likely to face complications passing on higher costs under the current insurance coverage contracts with locked-in yearly prices.

Casey Hite, CEO of Aeroflow Health, a firm that provides insurance-covered medical devices, said the following:

“With the level of tariffs that we’re looking at in China, businesses are going to be completely upside down on these products … they can’t pass those costs on to the consumer. I think what we would like to see, more than anything, is a runway or some predictability. Let’s do this over the next 12 months, next two years, so that US organizations can prepare.”

Our Methodology

We sifted through stock screeners, financial media reports, and ETFs to compile a list of 25 best medical device stocks and then chose the top 11 with the highest number of hedge fund holders as of Q4 2024. We sourced the hedge fund sentiment data from Insider Monkey’s database. The list is ordered in ascending order of hedge fund sentiment.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 363.5% since May 2014, beating its benchmark by 208 percentage points (see more details here).

Boston Scientific Corporation (NYSE:BSX)

Number of Hedge Fund Holders: 96

Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets medical devices used in interventional medical procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular segment covers Cardiology and Peripheral Interventions, while the MedSurg segment comprises Urology, Endoscopy, and Neuromodulation. The company ranks fourth on our list of the top medical device stocks to invest in.

On April 25, Barclays analyst Matt Miksic raised the firm’s price target on Boston Scientific Corporation (NYSE:BSX) to $125 from $118, keeping an Overweight rating on the shares. The firm reasoned that solid results from ADVANTAGE-AF for using Farawave and Farapoint in persistent atrial fibrillation should allow FDA approval later this year.

BTIG analyst Marie Thibault also maintained their bullish stance on the stock on April 23, giving it a buy rating based on its solid financial performance and promising outlook. Boston Scientific Corporation (NYSE:BSX) reported notable fiscal Q1 2025 revenue and EPS, surpassing both market expectations and its own guidance. The analyst attributed this success to higher-than-expected sales in electrophysiology and interventional cardiology. This holds especially true for the Farapulse franchise, which has positioned the company as a leader in the electrophysiology market.

Boston Scientific Corporation (NYSE:BSX) has raised its 2025 revenue guidance, and the upcoming CFO transition is expected to maintain stability in leadership, reflecting confidence in its stable growth and sustained profitability.

Overall, BSX ranks 4th on our list of the best medical device stocks to buy now. While we acknowledge the potential for BSX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than BSX but trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.